KK-LC-1×CD16Asolid tumorshematological malignancies
…esults We successfully developed a tetravalent NK cell engager, KK-LC-1×CD16A, which exhibits excellent binding affinity to its targets. CIML…
1articles mentioning drugs
2drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: KK-LC-1×CD16A ×
KK-LC-1×CD16A
This drug is selected. Its supporting articles are shown below.